Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
PDF 38kWORD 9k
16 March 2022
E-001031/2022
Question for written answer  E-001031/2022
to the Commission
Rule 138
Sara Skyttedal (PPE)
 Answer in writing 
 Subject: Harm reduction in tobacco policy

In its report on strengthening Europe in the fight against cancer (2020/2267(INI)), the European Parliament emphasises that other nicotine products play a role in reducing the use of cigarettes and bringing down rates of tobacco-related cancer (see paragraph 12). The report also calls on the Commission to compare the risks of using certain tobacco products with those of using other products.

In the light of the foregoing:

1. Does the Commission share Parliament’s view that other nicotine products play a role in reducing the use of cigarettes?

2. If so, what legislative initiatives will the Commission bring forward to see to it that cigarettes are superseded by other nicotine products?

3. Given its determination to combat cancer, is the Commission prepared to reconsider its previous positions on the status of snus within the EU’s internal market?

Original language of question: SV
Last updated: 23 March 2022Legal notice - Privacy policy